Related Experiment Video

Updated: Aug 17, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies

Jannis Kountouras1, Christos Zavos, Dimitrios Chatzopoulos

  • 1Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece. jannis@med.auth.gr

Journal of Surgical Oncology
|May 21, 2005
PubMed

Insights

Cancer management can be improved by inducing apoptosis, the programmed cell death process. Targeting angiogenesis, crucial for tumor growth and metastasis, offers new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Inappropriate suppression of apoptosis contributes significantly to cancer development.
  • Tumorigenesis involves mutations in tumor suppressor genes and overexpression of anti-apoptotic genes, promoting cell survival.
  • Angiogenesis is essential for tumor growth and metastasis.

Purpose of the Study:

  • To explore strategies for inducing apoptosis in cancer management.
  • To investigate new therapeutic targets for inhibiting angiogenesis in tumors.

Main Methods:

  • Review of current research on apoptosis induction in cancer therapy.
  • Analysis of molecular mechanisms underlying angiogenesis.
  • Identification of key markers in the angiogenic process for therapeutic targeting.

Main Results:

  • Inducing apoptosis presents a viable approach for cancer treatment.
  • Targeting angiogenesis is a promising strategy for controlling tumor growth and metastasis.
  • Several fundamental markers of angiogenesis are under investigation for novel therapeutic interventions.

Conclusions:

  • Modulating apoptosis and angiogenesis are critical therapeutic strategies in oncology.
  • Further research into targeting these processes holds promise for effective cancer management.

More Related Videos

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.